The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines

od Klenke, Stefanie, Akdeli, Neval, Stelmach, Patrick, Heukamp, Lukas, Schulte, Johannes H., Bachmann, Hagen S.
Izdano u BMC Cancer (2019)

The BCL2-938 C > A promoter polymorphism is associated with risk group classification in children with acute lymphoblastic leukemia

od Künkele, Annette, Grosse-Lordemann, Anja, Schramm, Alexander, Eggert, Angelika, Schulte, Johannes H, Bachmann, Hagen S
Izdano 2013

Immune response modulation by Galectin-1 in a transgenic model of neuroblastoma

od Büchel, Gabriele, Schulte, Johannes H., Harrison, Luke, Batzke, Katharina, Schüller, Ulrich, Hansen, Wiebke, Schramm, Alexander
Izdano u Oncoimmunology (2016)

Sinusoidal Obstruction Syndrome Following Myeloablative Therapy and Tranexamic Acid Treatment for Hemorrhage in Two Patients with Neuroblastoma

od Zirngibl, Felix, Flemmig, Carina, Lang, Peter, Künkele, Annette, Eggert, Angelika, Schulte, Johannes H., Deubzer, Hedwig E.
Izdano u Children (Basel) (2020)

Discovery of Spatial Peptide Signatures for Neuroblastoma Risk Assessment by MALDI Mass Spectrometry Imaging

od Wu, Zhiyang, Hundsdoerfer, Patrick, Schulte, Johannes H., Astrahantseff, Kathy, Boral, Senguel, Schmelz, Karin, Eggert, Angelika, Klein, Oliver
Izdano u Cancers (Basel) (2021)

The Lin28/let-7 axis is critical for myelination in the peripheral nervous system

od Gökbuget, Deniz, Pereira, Jorge A., Bachofner, Sven, Marchais, Antonin, Ciaudo, Constance, Stoffel, Markus, Schulte, Johannes H., Suter, Ueli
Izdano u Nat Commun (2015)

Oncogenic ALK(F1174L) drives tumorigenesis in cutaneous squamous cell carcinoma

od Gualandi, Marco, Iorio, Maria, Engeler, Olivia, Serra-Roma, André, Gasparre, Giuseppe, Schulte, Johannes H, Hohl, Daniel, Shakhova, Olga
Izdano u Life Sci Alliance (2020)

The MicroRNA Landscape of MYCN-Amplified Neuroblastoma

od Misiak, Danny, Hagemann, Sven, Bell, Jessica L., Busch, Bianca, Lederer, Marcell, Bley, Nadine, Schulte, Johannes H., Hüttelmaier, Stefan
Izdano u Front Oncol (2021)

Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma

od Bell, Jessica L., Hagemann, Sven, Holien, Jessica K., Liu, Tao, Nagy, Zsuzsanna, Schulte, Johannes H., Misiak, Danny, Hüttelmaier, Stefan
Izdano u Int J Mol Sci (2020)

Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells

od Pajtler, Kristian W., Mahlow, Ellen, Odersky, Andrea, Lindner, Sven, Stephan, Harald, Bendix, Ivo, Eggert, Angelika, Schramm, Alexander, Schulte, Johannes H.
Izdano u Oncotarget (2014)

Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

od Schwermer, Melanie, Lee, Sangkyun, Köster, Johannes, van Maerken, Tom, Stephan, Harald, Eggert, Angelika, Morik, Katharina, Schulte, Johannes H., Schramm, Alexander
Izdano u Oncotarget (2015)

CD57(high) Neuroblastoma Cells Have Aggressive Attributes Ex Situ and an Undifferentiated Phenotype in Patients

od Schlitter, Anne-Marie, Dorneburg, Carmen, Barth, Thomas F. E., Wahl, Joachim, Schulte, Johannes H., Brüderlein, Silke, Debatin, Klaus-Michael, Beltinger, Christian
Izdano 2012

Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma

od Launspach, Michael, Seif, Marita, Thole, Theresa M., Jesse, Patrick, Schulz, Joachim, Schulte, Johannes H., Bischoff, Susan, Eggert, Angelika, Deubzer, Hedwig E.
Izdano u Children (Basel) (2021)

Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma

od LINDNER, SVEN, BACHMANN, HAGEN S., ODERSKY, ANDREA, SCHAEFERS, SIMON, KLEIN-HITPASS, LUDGER, HERO, BARBARA, FISCHER, MATTHIAS, EGGERT, ANGELIKA, SCHRAMM, ALEXANDER, SCHULTE, JOHANNES H.
Izdano u Biomed Rep (2015)

The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapse

od Riehl, Lara M., Schulte, Johannes H., Mulaw, Medhanie A., Dahlhaus, Meike, Fischer, Matthias, Schramm, Alexander, Eggert, Angelika, Debatin, Klaus-Michael, Beltinger, Christian
Izdano u Oncotarget (2015)

Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma

od Arnhold, Viktor, Schmelz, Karin, Proba, Jutta, Winkler, Annika, Wünschel, Jasmin, Toedling, Joern, Deubzer, Hedwig E., Künkele, Annette, Eggert, Angelika, Schulte, Johannes H., Hundsdoerfer, Patrick
Izdano u Oncotarget (2017)

Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

od Schulte, Johannes H., Marschall, Tobias, Martin, Marcel, Rosenstiel, Philipp, Mestdagh, Pieter, Schlierf, Stefanie, Thor, Theresa, Vandesompele, Jo, Eggert, Angelika, Schreiber, Stefan, Rahmann, Sven, Schramm, Alexander
Izdano 2010

RITA displays anti-tumor activity in medulloblastomas independent of TP53 status

od Gottlieb, Aline, Althoff, Kristina, Grunewald, Laura, Thor, Theresa, Odersky, Andrea, Schulte, Marc, Deubzer, Hedwig E., Heukamp, Lukas, Eggert, Angelika, Schramm, Alexander, Schulte, Johannes H., Künkele, Annette
Izdano u Oncotarget (2017)

Chromosomal and miRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q− Neuroblastoma

od Buckley, Patrick G, Alcock, Leah, Bryan, Kenneth, Bray, Isabella, Schulte, Johannes H, Schramm, Alexander, Eggert, Angelika, Mestdagh, Pieter, De Preter, Katleen, Vandesompele, Jo, Speleman, Frank, Stallings, Raymond L
Izdano 2010

Prohibitin promotes dedifferentiation and is a potential therapeutic target in neuroblastoma

od MacArthur, Ian C., Bei, Yi, Garcia, Heathcliff Dorado, Ortiz, Michael V., Toedling, Joern, Klironomos, Filippos, Rolff, Jana, Eggert, Angelika, Schulte, Johannes H., Kentsis, Alex, Henssen, Anton G.
Izdano u JCI Insight (2019)